Asian Journal of Sports Medicine

Published by: Kowsar

Short-Acting Insulin Reduction Strategies for Continuous Cycle Ergometer Exercises in Patients with Type 1 Diabetes Mellitus

Othmar Moser 1 , 2 , 3 , * , Gerhard Tschakert 2 , Alexander Mueller 2 , 4 , Werner Groeschl 2 , Peter Hofmann 2 , Thomas Pieber 1 , Jimmy Lawrence 5 and Gerd Koehler 1
Authors Information
1 Department of Internal Medicine, Medical University of Graz, Graz, Austria
2 Institute of Sport Science, University of Graz, Graz, Austria
3 Applied Sport, Technology, Exercise and Medicine Research Centre (A-STEM), Swansea University, Swansea, United Kingdom
4 Sports Science Laboratory, FH JOANNEUM-University of Applied Sciences, Bad Gleichenberg, Austria
5 Sociology of Physical Activity and Health, University of Potsdam, Potsdam, Germany
Article information
  • Asian Journal of Sports Medicine: March 2017, 8 (1); e42160
  • Published Online: January 4, 2017
  • Article Type: Research Article
  • Received: September 12, 2016
  • Revised: November 8, 2016
  • Accepted: December 12, 2016
  • DOI: 10.5812/asjsm.42160

To Cite: Moser O, Tschakert G, Mueller A, Groeschl W, Hofmann P, et al. Short-Acting Insulin Reduction Strategies for Continuous Cycle Ergometer Exercises in Patients with Type 1 Diabetes Mellitus, Asian J Sports Med. 2017 ; 8(1):e42160. doi: 10.5812/asjsm.42160.

Copyright © 2017, Sports Medicine Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
  • 1. Kodama S, Tanaka S, Heianza Y, Fujihara K, Horikawa C, Shimano H, et al. Association between physical activity and risk of all-cause mortality and cardiovascular disease in patients with diabetes: a meta-analysis. Diabetes Care. 2013; 36(2): 471-9[DOI][PubMed]
  • 2. Leroux C, Gingras V, Desjardins K, Brazeau AS, Ott-Braschi S, Strychar I, et al. In adult patients with type 1 diabetes healthy lifestyle associates with a better cardiometabolic profile. Nutr Metab Cardiovasc Dis. 2015; 25(5): 444-51[DOI][PubMed]
  • 3. Brazeau AS, Rabasa-Lhoret R, Strychar I, Mircescu H. Barriers to physical activity among patients with type 1 diabetes. Diabetes Care. 2008; 31(11): 2108-9[DOI][PubMed]
  • 4. Galassetti P, Riddell MC. Exercise and Type 1 Diabetes (T1DM). Compr Physiol. 2013; : 1309-36[DOI]
  • 5. West DJ, Morton RD, Bain SC, Stephens JW, Bracken RM. Blood glucose responses to reductions in pre-exercise rapid-acting insulin for 24 h after running in individuals with type 1 diabetes. J Sports Sci. 2010; 28(7): 781-8[DOI][PubMed]
  • 6. Rabasa-Lhoret R, Bourque J, Ducros F, Chiasson JL. Guidelines for premeal insulin dose reduction for postprandial exercise of different intensities and durations in type 1 diabetic subjects treated intensively with a basal-bolus insulin regimen (ultralente-lispro). Diabetes Care. 2001; 24(4): 625-30[PubMed]
  • 7. Campbell MD, Walker M, Bracken RM, Turner D, Stevenson EJ, Gonzalez JT, et al. Insulin therapy and dietary adjustments to normalize glycemia and prevent nocturnal hypoglycemia after evening exercise in type 1 diabetes: a randomized controlled trial. BMJ Open Diabetes Res Care. 2015; 3(1): 85[DOI][PubMed]
  • 8. Franc S, Daoudi A, Pochat A, Petit MH, Randazzo C, Petit C, et al. Insulin-based strategies to prevent hypoglycaemia during and after exercise in adult patients with type 1 diabetes on pump therapy: the DIABRASPORT randomized study. Diabetes Obes Metab. 2015; 17(12): 1150-7[DOI][PubMed]
  • 9. Francescato MP, Geat M, Accardo A, Blokar M, Cattin L, Noacco C. Exercise and glycemic imbalances: a situation-specific estimate of glucose supplement. Med Sci Sports Exerc. 2011; 43(1): 2-11[DOI][PubMed]
  • 10. West DJ, Stephens JW, Bain SC, Kilduff LP, Luzio S, Still R, et al. A combined insulin reduction and carbohydrate feeding strategy 30 min before running best preserves blood glucose concentration after exercise through improved fuel oxidation in type 1 diabetes mellitus. J Sports Sci. 2011; 29(3): 279-89[DOI][PubMed]
  • 11. Conway B, Miller RG, Costacou T, Fried L, Kelsey S, Evans RW, et al. Temporal patterns in overweight and obesity in Type 1 diabetes. Diabet Med. 2010; 27(4): 398-404[DOI][PubMed]
  • 12. Gallen IW, Hume C, Lumb A. Fuelling the athlete with type 1 diabetes. Diabetes Obes Metab. 2011; 13(2): 130-6[DOI][PubMed]
  • 13. Dzygalo K, Golicki D, Kowalska A, Szypowska A. The beneficial effect of insulin degludec on nocturnal hypoglycaemia and insulin dose in type 1 diabetic patients: a systematic review and meta-analysis of randomised trials. Acta Diabetol. 2015; 52(2): 231-8[DOI][PubMed]
  • 14. Yamamoto C, Miyoshi H, Fujiwara Y, Kameda R, Ichiyama M, Nomoto H, et al. Degludec is superior to glargine in terms of daily glycemic variability in people with type 1 diabetes mellitus. Endocr J. 2016; 63(1): 53-60[DOI][PubMed]
  • 15. Nakamura T, Sakaguchi K, So A, Nakajima S, Takabe M, Komada H, et al. Effects of insulin degludec and insulin glargine on day-to-day fasting plasma glucose variability in individuals with type 1 diabetes: a multicentre, randomised, crossover study. Diabetologia. 2015; 58(9): 2013-9[DOI][PubMed]
  • 16. Koehler G, Heller S, Korsatko S, Roepstorff C, Rasmussen S, Haahr H, et al. Insulin degludec is not associated with a delayed or diminished response to hypoglycaemia compared with insulin glargine in type 1 diabetes: a double-blind randomised crossover study. Diabetologia. 2014; 57(1): 40-9[DOI][PubMed]
  • 17. Moser O, Tschakert G, Mueller A, Groeschl W, Pieber TR, Obermayer-Pietsch B, et al. Effects of High-Intensity Interval Exercise versus Moderate Continuous Exercise on Glucose Homeostasis and Hormone Response in Patients with Type 1 Diabetes Mellitus Using Novel Ultra-Long-Acting Insulin. PLoS One. 2015; 10(8)[DOI][PubMed]
  • 18. Heise T, Bain SC, Bracken RM, Zijlstra E, Nosek L, Stender-Petersen K, et al. Similar risk of exercise-related hypoglycaemia for insulin degludec to that for insulin glargine in patients with type 1 diabetes: a randomized cross-over trial. Diabetes Obes Metab. 2016; 18(2): 196-9[DOI][PubMed]
  • 19. Bracken RM, West DJ, Stephens JW, Kilduff LP, Luzio S, Bain SC. Impact of pre-exercise rapid-acting insulin reductions on ketogenesis following running in Type 1 diabetes. Diabet Med. 2011; 28(2): 218-22[DOI][PubMed]
  • 20. Campbell MD, Walker M, Trenell MI, Jakovljevic DG, Stevenson EJ, Bracken RM, et al. Large pre- and postexercise rapid-acting insulin reductions preserve glycemia and prevent early- but not late-onset hypoglycemia in patients with type 1 diabetes. Diabetes Care. 2013; 36(8): 2217-24[DOI][PubMed]
  • 21. Hofmann P, Tschakert G. Special needs to prescribe exercise intensity for scientific studies. Cardiol Res Pract. 2010; 2011: 209302[DOI][PubMed]
  • 22. Scharhag-Rosenberger F, Meyer T, Gassler N, Faude O, Kindermann W. Exercise at given percentages of VO2max: heterogeneous metabolic responses between individuals. J Sci Med Sport. 2010; 13(1): 74-9[DOI][PubMed]
  • 23. Ratjen I, Weber KS, Roden M, Herrmann ME, Mussig K. Type 1 diabetes mellitus and exercise in competitive athletes. Exp Clin Endocrinol Diabetes. 2015; 123(7): 419-22[DOI][PubMed]
  • 24. Jenni S, Oetliker C, Allemann S, Ith M, Tappy L, Wuerth S, et al. Fuel metabolism during exercise in euglycaemia and hyperglycaemia in patients with type 1 diabetes mellitus--a prospective single-blinded randomised crossover trial. Diabetologia. 2008; 51(8): 1457-65[DOI][PubMed]
  • 25. Chokkalingam K, Tsintzas K, Norton L, Jewell K, Macdonald IA, Mansell PI. Exercise under hyperinsulinaemic conditions increases whole-body glucose disposal without affecting muscle glycogen utilisation in type 1 diabetes. Diabetologia. 2007; 50(2): 414-21[DOI][PubMed]
  • 26. Stettler C, Jenni S, Allemann S, Steiner R, Hoppeler H, Trepp R, et al. Exercise capacity in subjects with type 1 diabetes mellitus in eu- and hyperglycaemia. Diabetes Metab Res Rev. 2006; 22(4): 300-6[DOI][PubMed]
  • 27. Tschakert G, Kroepfl J, Mueller A, Moser O, Groeschl W, Hofmann P. How to regulate the acute physiological response to "aerobic" high-intensity interval exercise. J Sports Sci Med. 2015; 14(1): 29-36[PubMed]
  • 28. Cryer PE. Hypoglycaemia: the limiting factor in the glycaemic management of Type I and Type II diabetes. Diabetologia. 2002; 45(7): 937-48[DOI][PubMed]
  • 29. Heise T, Hermanski L, Nosek L, Feldman A, Rasmussen S, Haahr H. Insulin degludec: four times lower pharmacodynamic variability than insulin glargine under steady-state conditions in type 1 diabetes. Diabetes Obes Metab. 2012; 14(9): 859-64[DOI][PubMed]
  • 30. Hermansen K, Fontaine P, Kukolja KK, Peterkova V, Leth G, Gall MA. Insulin analogues (insulin detemir and insulin aspart) versus traditional human insulins (NPH insulin and regular human insulin) in basal-bolus therapy for patients with type 1 diabetes. Diabetologia. 2004; 47(4): 622-9[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments